Discovery of key protein behind cancer relapse and progression can lead to new therapies
Cancer cases have been rising over the years and according to the statistics, the number of people living with cancer […]
Read More.Category: Cancer
Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells
In a new study, researchers report that they have dramatically broadened the potential targets of CAR-T therapy – their engineered T-cells attack a variety of solid-tumour cancer cells from humans and mice.
Read More.Artificial intelligence can categorise cancer risk of lung nodules
A study published in American Journal of Respiratory and Critical Care Medicine indicates that an artificial intelligence strategy can correctly assess and categorise these indeterminate pulmonary nodules (IPNs).
Read More.New pathway to attack tumour cells identified
A study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumour causing cell destruction by autophagy.
Read More.Changes to gut microbiome may slow cancer growth in smokers
Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2020.
Read More.Schizophrenia drug combined with radiation shows promise in treating deadly brain tumours
Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumours.
Read More.Associations between immune-suppressive and stimulating drugs and novel COVID-19 — a systematic review of current evidence
Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases, especially as they may be treated with immune-suppressive or immune-stimulating drugs. This review focuses on the effects of these drugs on host immunity against COVID-19.
Read More.How to manage cancer care during COVID-19 pandemic
Experts from the Seattle Cancer Care Alliance (SCCA)—a Member Institution of the National Comprehensive Cancer Network (NCCN)—are sharing insights and advice on how to continue providing optimal cancer care during the novel coronavirus (COVID-19) pandemic.
Read More.Doctors investigate commonly used medications that may worsen COVID-19, or even help fight it
A study has found there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen […]
Read More.CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research
A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types.
Read More.
